HomeAVTX • NASDAQ
add
Avalo Therapeutics Inc
Previous close
$9.30
Day range
$9.31 - $10.25
Year range
$3.95 - $71.04
Market cap
9.99M USD
Avg Volume
9.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 6.62M | 89.43% |
Net income | 98.46M | 1,301.79% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.44M | -32.78% |
Effective tax rate | 0.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 93.43M | 1,381.31% |
Total assets | 108.31M | 346.90% |
Total liabilities | 110.46M | 253.99% |
Total equity | -2.15M | — |
Shares outstanding | 1.03M | — |
Price to book | -0.71 | — |
Return on assets | -20.41% | — |
Return on capital | 47.51% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 98.46M | 1,301.79% |
Cash from operations | -16.28M | -47.68% |
Cash from investing | 0.00 | — |
Cash from financing | -472.00K | -178.93% |
Net change in cash | -16.76M | -60.67% |
Free cash flow | -125.65M | -1,457.77% |
About
Founded
2011
Headquarters
Website
Employees
19